Anti-CD3 monoclonal antibody

Results: 4



#Item
1COMMENTARY  Therapeutic Targeting of B Cells and T Cells in Autoimmune Diabetes Is It a Solution? Lucienne Chatenoud

COMMENTARY Therapeutic Targeting of B Cells and T Cells in Autoimmune Diabetes Is It a Solution? Lucienne Chatenoud

Add to Reading List

Source URL: diabetes.diabetesjournals.org

Language: English
2A Single Course of Anti-CD3 Monoclonal Antibody hOKT3␥1(Ala-Ala) Results in Improvement in C-Peptide Responses and Clinical Parameters for at Least 2 Years after Onset of Type 1 Diabetes Kevan C. Herold,1 Stephen E. Gi

A Single Course of Anti-CD3 Monoclonal Antibody hOKT3␥1(Ala-Ala) Results in Improvement in C-Peptide Responses and Clinical Parameters for at Least 2 Years after Onset of Type 1 Diabetes Kevan C. Herold,1 Stephen E. Gi

Add to Reading List

Source URL: diabetes.diabetesjournals.org

Language: English - Date: 2005-05-10 10:04:46
3ZENAPAX (daclizumab) STERILE CONCENTRATE FOR INJECTION Rx only WARNING Only physicians experienced in immunosuppressive therapy and management of

ZENAPAX (daclizumab) STERILE CONCENTRATE FOR INJECTION Rx only WARNING Only physicians experienced in immunosuppressive therapy and management of

Add to Reading List

Source URL: www.gene.com

Language: English - Date: 2014-03-31 07:24:10
4Editorial For reprint orders, please contact [removed] EBV infection and anti-CD3 treatment for Type 1 diabetes: bad cop, good cop? Expert Rev. Clin. Immunol. 9(2), 95–[removed])

Editorial For reprint orders, please contact [removed] EBV infection and anti-CD3 treatment for Type 1 diabetes: bad cop, good cop? Expert Rev. Clin. Immunol. 9(2), 95–[removed])

Add to Reading List

Source URL: www.faustmanlab.org

Language: English - Date: 2013-12-11 22:21:47